{
    "clinical_study": {
        "@rank": "119492", 
        "acronym": "ADIMS", 
        "brief_summary": {
            "textblock": "The investigators are measuring the adherence rates of an oral MS drug that is to be\n      administered twice-daily. The investigators would like to observe any patterns that might\n      indicate factors that greatly affect adherence."
        }, 
        "brief_title": "Adherence to Treatment With Tecfidera\u2122 in Multiple Sclerosis Patients", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Multiple Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Multiple Sclerosis", 
                "Sclerosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Must give written informed consent and any authorizations required by local law\n             (e.g., Protected Health Information [PHI]).\n\n          -  Aged 18 at the time of informed consent.\n\n          -  Must have a relapsing form of MS.\n\n          -  Male subjects and female subjects of child-bearing potential (including female\n             subjects who are not post-menopausal for at least 1 year) must be willing to practice\n             effective contraception (as defined by the investigator) during the study and be\n             willing and able to continue contraception for 30 days after their last dose of study\n             treatment.\n\n        Exclusion Criteria:\n\n          -  Progressive form of MS\n\n          -  History of severe allergic or anaphylactic reactions or known drug hypersensitivity.\n\n          -  Female subjects considering becoming pregnant while in the study.\n\n          -  Female subjects who are currently pregnant or breast-feeding.\n\n          -  Unwillingness or inability to comply with the requirements of the protocol including\n             the presence of any conditional (physical, mental or social) that is likely to affect\n             the subject's ability to comply with the protocol.\n\n          -  Any other reason that, in opinion of the Investigator and/or the Sponsor, the subject\n             is determined to be unsuitable for enrollment in this study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "community sample of Multiple Sclerosis patients started on Tecfidera"
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02099370", 
            "org_study_id": "US-BGT-13-10458"
        }, 
        "intervention_browse": {
            "mesh_term": "Dimethyl fumarate"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Multiple Sclerosis", 
            "Tecfidera(R)", 
            "Oral medication", 
            "Adherence"
        ], 
        "lastchanged_date": "March 27, 2014", 
        "location": {
            "contact": {
                "email": "aaungst@health.usf.edu", 
                "last_name": "Angela Augnst, MPH", 
                "phone": "813-974-6378"
            }, 
            "contact_backup": {
                "email": "lpearsal@health.usf.edu", 
                "last_name": "Laurie Pearsall, LPN", 
                "phone": "813-974-9424"
            }, 
            "facility": {
                "address": {
                    "city": "Tampa", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "33612"
                }, 
                "name": "USF Carol and Frank Morsani Center for Advanced Healthcare"
            }, 
            "investigator": [
                {
                    "last_name": "Derrick Robertson, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Lise Casady, ARNP", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Angela Aungst, MPH", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Laurie Pearsall, LPN", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Single-center Prospective Measurement of Adherence to Treatment With Tecfidera\u2122 in Multiple Sclerosis Patients.", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "adherence rates to Tecfidera", 
            "safety_issue": "No", 
            "time_frame": "over one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02099370"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of South Florida", 
            "investigator_full_name": "Derrick Scott Robertson", 
            "investigator_title": "MD, Multiple Sclerosis Center Director", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of South Florida", 
        "sponsors": {
            "collaborator": {
                "agency": "Biogen Idec", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "University of South Florida", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}